Foghorn sounds another warning about the class of ‘20
In 2020 76 biotech floats raised a combined $12.7bn. Foghorn is not the first to show that much of the faith was misplaced.
TG slips out a nasty surprise for investors
Yet another US clinical hold hits, and this time the unlucky recipient is TG Therapeutics.
A late Christmas present for Allogene
US clinical hold over Allogene’s entire pipeline has just been lifted.
Allogene raises the spectre of a Car-T nightmare
Little is known about yesterday’s clinical hold on Allogene’s entire pipeline, but chromosomal abnormalities hint at a worst-case scenario.
